| Who gets Barrett's esophagus and could I have it? |
|
Brown LM and Devesa S, Epidemiologic trends in esophageal and gastric cancer in the United States. Surgical Oncology Clinics of North America, 2002. 11: p. 235-56. |
|
Brown LM, Swanson CA, Gridley G, Swanson GM, Schoenberg JB, Greenberg RS, Silverman DT, Pottern LM, Hayes RB, Schwartz AG, et al. Adenocarcinoma of the esophagus: role of obesity and diet. J Natl Cancer Inst 1995; 87(2):104-9. |
|
Cameron AJ, Lagergren J, Henriksson C, Nyren O, Locke GR, and Pedersen NL, Gastroesophageal reflux disease in monozygotic and dizygotic twins. Gastroenterology, 2002. 122(1): p. 55-9. |
|
Cameron AJ, Lomboy CT. Barrett's esophagus: age, prevalence, and extent of columnar epithelium [see comments]. Gastroenterology 1992; 103(4):1241-5. |
|
Cameron AJ, Zinsmeister AR, Ballard DJ, Carney JA. Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings [see comments]. Gastroenterology 1990; 99(4):918-22. |
|
Castell D. Overview of the clinical spectrum of gastroesophageal reflux disease. Practical Gastroenterology 1999; 23(10):43. |
|
Chak A, Lee T, Kinnard MF, Brock W, Faulx A, Willis J, Cooper GS, Sivak MV, Jr., and Goddard KA, Familial aggregation of Barrett's oesophagus, oesophageal adenocarcinoma, and oesophagogastric junctional adenocarcinoma in Caucasian adults. Gut, 2002. 51(3): p. 323-8. |
|
Chow WH, Blot WJ, Vaughan TL, Risch HA, Gammon MD, Stanford JL, Dubrow R, et al. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. Journal Of The National Cancer Institute 1998; 90(2):150-5. |
|
Collen MJ, Lewis JH, Benjamin SB. Gastric acid hypersecretion in refractory gastroesophageal reflux disease [see comments]. Gastroenterology 1990; 98(3):654-61. |
|
Crabb DW, Berk MA, Hall TR, Conneally PM, Biegel AA, Lehman GA. Familial gastroesophageal reflux and development of Barrett's esophagus. Annals Of Internal Medicine 1985; 103(1):52-4. |
|
Day JP, Richter JE. Medical and surgical conditions predisposing to gastroesophageal reflux disease. Gastroenterol Clin North Am 1990; 19(3):587-607. |
|
Devesa SS, Blot WJ, Fraumeni JF, Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998; 83(10):2049-53. |
|
Engel LS, Chow WH, Vaughan TL, Gammon MD, Risch HA, Stanford JL, Schoenberg JB, Mayne ST, Dubrow R, Rotterdam H, West AB, Blaser M, Blot WJ, Gail MH, and Fraumeni JF, Population attributable risks of esophageal and gastric cancers. Journal of the National Cancer Institute, 2003. 95(18): p. 1404-13. |
|
Fahmy N, King JF. Barrett's esophagus: an acquired condition with genetic predisposition [see comments]. American Journal Of Gastroenterology 1993; 88(8):1262-5. |
|
Hogan W, Dodds W. Gastroesophageal reflux disease (reflux esophagitis). In: Sleisenger MH FJ, ed. Gastrointestinal disease, ed. 4th. Philadelphia: Saunders, 1989; 594-619. |
|
Jochem VJ, Fuerst PA, Fromkes JJ. Familial Barrett's esophagus associated with adenocarcinoma. Gastroenterology 1992; 102(4 Pt 1):1400-2. |
|
Johnson DA, Winters C, Spurling TJ, Chobanian SJ, Cattau ELJ. Esophageal acid sensitivity in Barrett's esophagus. Journal Of Clinical Gastroenterology 1987; 9(1):23-7. |
|
Kahrilas P. Gastroesophageal reflux disease and its complications. In: Feldman M SM, Scharschmidt BF, ed. Sleisenger and Fortran's Gastrointestinal and Liver Disease, ed. 6th ed. Philadelphia, PA: WB Saunders Co, 1998; 498-517. |
|
Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 340(11):825-31. |
|
Lerut T. The prognosis of Barrett's esophagus and its relationship with gastroesophageal reflux disease. In: Büchler MW FE, Klaiber Ch, Krähenbühl L, ed. Gastroesophageal Reflux Disease (GERD): Back to Surgery? Progress in Surgery, vol. 23, 1997; 98-105. |
|
Locke GR, 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ, 3rd. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997; 112(5):1448-56. |
|
Morales TG, Sampliner RE. Barrett's esophagus: update on screening, surveillance, and treatment. Arch Intern Med 1999; 159(13):1411-6. |
|
Nebel OT, Fornes MF, Castell DO. Symptomatic gastroesophageal reflux: incidence and precipitating factors. American Journal Of Digestive Diseases 1976; 21(11):953-6. |
|
Phillips RW, Wong RK. Barrett's esophagus. Natural history, incidence, etiology, and complications. Gastroenterology Clinics of North America 1991; 20(4):791-816. |
|
Romero Y, Cameron AJ, Schaid DJ, McDonnell SK, Burgart LJ, Hardtke CL, Murray JA, Locke GR. Barrett's esophagus: prevalence in symptomatic relatives. The American Journal of Gastroenterology 2002; 97(5):1127-32. |
| Ronkainen J, Aro P,
Storskrubb T, Johansson S-E, Lind T, Bolling-Sternevald E, Vieth M,
Stolte M, Talley N, Agreus L. Prevalence of Barrett's esophagus in
the general population: An endoscopic study. Gastroenterology
2005;129: 1825-1831. |
|
Sonnenberg A. Epidemiology of gastroesophageal reflux disease. In: Büchler MW FE, Klaiber Ch, Krähenbühl L, ed. Gastroesophageal Reflux Disease (GERD): Back to Surgery? Progress in Surgery, vol. 23, 1997; 20-35. |
|
Spechler SJ. Barrett's esophagus: what's new and what to do. American Journal Of Gastroenterology 1989; 84(3):220-3. |
| Stein DJ, El-Serag HB,
Kuczynski SJ, Kramer JR, Sampliner RE. The association of body mass
index with Barrett's oesophagus. Aliment Pharmacol Ther 2005; 22:
1005-1010. |
|
Trudgill NJ, Kapur KC, Riley SA. Familial clustering of reflux symptoms. American Journal of Gastroenterology 1999; 94(5):1172-8. |
|
Vaughan TL, Davis S, Kristal A, Thomas DB. Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 1995; 4(2):85-92. |
|
Winters C, Jr., Spurling TJ, Chobanian SJ, Curtis DJ; Esposito RL; Hacker JF 3rd, Johnson DA; Cruess DF; Cetelingam JD; Gurney MS, et al. Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology 1987; 92(1):118-24. |
|
